Cellular adoptive immunotherapy after autologous and allogeneic hematopoietic stem cell transplantation.
Porter
David L
DL
Division of Hematology-Oncology, University of Pennsylvania Medical Center, 16 Penn Tower, 3400 Spruce St, Philadelphia, PA, USA. david.porter@uphs.upenn.edu
Hexner
Elizabeth O
EO
Cooley
Sarah
S
Miller
Jeffrey S
JS
D000818:Animals; D001854:Bone Marrow Cells / Q000166:cytology; D018572:Disease-Free Survival; D020544:Graft vs Leukemia Effect; D019337:Hematologic Neoplasms / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods*; D007694:Killer Cells, Natural / Q000166:cytology; D051379:Mice; D008954:Models, Biological; D013997:Time Factors; D014182:Transplantation, Autologous / Q000379:methods*; D014184:Transplantation, Homologous / Q000379:methods*